
Intra-Arterial Paraplatin Shows No Hearing Loss in Retinoblastoma
Hearing loss was not linked to intra-arterial Paraplatin (carboplatin) when measured using distortion product otoacoustic emission measurement (DPOAE) testing in children with retinoblastoma, according to study findings presented at the 50th Annual …